Qlaris Bio, Inc.
Clinical trials sponsored by Qlaris Bio, Inc., explained in plain language.
-
New eye drops aim to boost blood flow in diabetic retinopathy and glaucoma
Disease control Recruiting nowThis study tests an eye drop called QLS-111 in 14 people with diabetic retinopathy or certain types of glaucoma. The goal is to see if it can improve blood flow to the back of the eye. Participants will receive the drops and have their eyes imaged over several weeks.
Phase: PHASE2 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 06:21 UTC
-
New eye drop combo aims to lower glaucoma pressure
Disease control Recruiting nowThis study is testing a new preservative-free eye drop combination (QLS-111-FDC) to see how well it lowers eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 participants will receive the study drops and be monitored for safety and comfort. The goal …
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC